Bradley J. Fikes
The Union-Tribune
San Diego, CA, United States
Contact Bradley
Discover and connect with journalists and influencers around the world, save time on email research, monitor the news, and more.
| Recent: |
|
| Past: |
|
Past articles by Bradley:
Ionis honors its navigating CEO
Ionis honors CEO the Navigator, and a new start at USC → Read More
Biotech veteran David Hale chosen for Connect Hall of Fame
Longtime biomedical champion gets top Innovation Awards honor → Read More
Neurana's non-opioid back pain drug passes midstage human testing
Neurana's non-opioid pain drug passes midstage human testing. Called tolperisone, the drug showed effectiveness for back spasms with drowsiness comparable to placebo → Read More
Ionis subsidiary Akcea ousts leadership team
Ionis subsidiary Akcea ousts leadership team. Biotech veteran Damien McDevitt takes over as interim CEO. → Read More
UCSD's Center for Novel Therapeutics brings cancer researchers, industry, together
UC San Diego’s Center for Novel Therapeutics brings cancer researchers, industry, together. Infection survivor says constant support as well as medicine needed for recovery. → Read More
Fate Therapeutics raises $173 million in offering
Fate Therapeutics raises $173 million in offering. Proceeds to advance clinical testing and research on immune cell therapies for cancer. → Read More
San Diego startup raises nearly $47 million for new approach to fighting cancer
Promising an entirely new approach to fighting cancer, San Diego's Boundless Bio has raised $46.4 million in venture funding. The startup, led by local biotech veterans, was founded on research into the cancer-promoting role of DNA outside of chromosomes that normally is found inside them. → Read More
Turning Point Therapeutics raises $202 million for cancer therapy
Turning Point Therapeutics raises $202 million more for cancer therapy. San Diego biotech's total exceeds its initial public offering in April. → Read More
Heart attack treatment gel shows safety in early human study
Heart attack treatment gel shows safety in early human study. San Diego's Ventrix says treatment also shows preliminary signs of efficacy. → Read More
San Diego Zoo brings in president and CEO from Disney
Movie executive and conservationist Paul Baribault of Walt Disney Studios takes over Oct. 1 → Read More
Brain cancer drug from San Diego's Tocagen fails late-stage testing, shares dive
Bad news for brain cancer patients puts company's existence in doubt → Read More
San Diego's ZeaKal raises $15 million, expands programs for hemp, other crops
San Diego's ZeaKal raises $15 million, expands crop efficiency programs for such crops as hemp. Agbiotech company brings on top seed executive to build business. → Read More
MDA muscle walk celebrates progress, but much work remains ahead
Star Wars cosplayers and hundreds of mundanes gathered at Crown Point Park Saturday morning to help the Muscular Dystrophy Association turn cures from science fiction into reality. → Read More
Reproductive malfeasance enabled by technology, new book says
Technology failures and broken contracts represent the dark side of the boom in reproductive medicine. How courts should respond is the theme of a new book by bioethicist Dov Fox, director of the University of San Diego's Center for Health Law Policy & Bioethics. → Read More
From rock/paper/scissors to new cancer-fighting concept from UCSD scientists
Using a concept from a childrens' game, UC San Diego synthetic biology scientists say they've found a way to turn genetically modified bacteria into stable vehicles for delivering drugs for diseases such as cancer. → Read More
Carlsbad startup seeks to put blood tests on microchips
In an instrument-packed garage in Carlsbad, Octavian and Ana Florescu are working to apply the power of microchips to quickly and cheaply run common analytical tests on blood. The company they founded, In Diagnostics, has raised $3 million to get that technology to market → Read More
Cidara gets $30M upfront, possibly hundreds of millions more, for its antifungal drug
San Diego's Cidara gets $30M upfront, possibly hundreds of millions more, for its antifungal drug. Rezafungin developed for drug-resistant fungal infections of Candida. → Read More
To raise money from male investors, this female biotech CEO examined how men think
Evofem CEO Saundra Pelletier explains her approach at meeting to support women in science → Read More
Progress in understanding Alzheimer's disease genetics, hope remains for drugs in testing
Maria Carrillo, chief science officer of the Alzheimer's Association, shares new insights on the disease → Read More
Devoted parents, they purify the environment: Meet the vultures
Meet the vultures as they really are: Intelligent, devoted parents, they purify the environment. San Diego Zoo Safari Park holds Vulture Awareness Weekend to showcase these misunderstood birds. → Read More